Lipiodol avidity of hepatic breast carcinoma metastases

R A Boyle; P M Hewitt; D L Morris

Lipiodol avidity of hepatic breast carcinoma metastases

Anticancer Res. 2001 Sep-Oct;21(5):3725-7.

Authors

R A Boyle¹, P M Hewitt, D L Morris

Affiliation

¹ UNSW Department of Surgery, St George Hospital, Sydney, Australia.

PMID: 11848552

Abstract

Lipiodol is taken up by hepatocellular carcinomas and is used for diagnosis and therapy. This is the first report of lipiodol uptake by liver metastases from breast cancer.

Publication types

Case Reports

MeSH terms

Breast Neoplasms / metabolism*
Breast Neoplasms / pathology
Contrast Media / pharmacokinetics*
Female
Humans
Iodized Oil / pharmacokinetics*
Liver Neoplasms / metabolism*
Liver Neoplasms / secondary*
Middle Aged

Substances

Contrast Media
Iodized Oil